A phase I first-in-human trial to investigate PTI-125

Trial Profile

A phase I first-in-human trial to investigate PTI-125

Planning
Phase of Trial: Phase I

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs PTI-125 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 09 Aug 2017 According to a Pain Therapeutics media release, the FDA has cleared the IND application for PTI-125.
    • 02 Aug 2017 New trial record
    • 31 Jul 2017 Results from this trial are expected by year-end 2017, according to a Pain Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top